Although the clinical literature abounds with promises which the short-acting barbiturates are remarkable for developing slumber when the intermediate-acting compounds are more effective in protecting rest, managed experiments have didn't display these differential effects. As a result, as rest drugs, the barbiturates are of restricted price over a